Skinvisible (SKVI) Other Non-Current Liabilities (2021 - 2024)
Skinvisible's (SKVI) quarterly Other Non-Current Liabilities came in at $22420.0 in Q4 2024, up 20.9% year-over-year from $18544.0 in Q1 2024, and up 205.12% quarter-over-quarter from $7348.0 in Q3 2024.
Powered by 
Analysis
Skinvisible (SKVI) Other Non-Current Liabilities (2021 - 2024) Analysis & Trends
Skinvisible has disclosed Other Non-Current Liabilities across 4 years of filings, most recently posting $22420.0 for Q4 2024.
- In Q4 2024, Other Non-Current Liabilities rose 20.9% year-over-year to $22420.0; the TTM figure through Dec 2024 stood at $22420.0 (up 20.9% YoY), while the FY2024 annual figure was $22420.0, up 20.9% from the prior year.
- Other Non-Current Liabilities came in at $22420.0 for Q4 2024 at Skinvisible, up from $7348.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $190669.0 in Q2 2021 to a low of $7348.0 in Q3 2024.
- Average Other Non-Current Liabilities over 4 years is $37623.6, with a median of $20634.5 recorded in 2022.
- Year-over-year, Other Non-Current Liabilities slumped 88.35% in 2022 and soared 36.06% in 2023.
- Over 4 years, Other Non-Current Liabilities stood at $45664.0 in 2021, then slumped by 70.15% to $13629.0 in 2022, then soared by 36.06% to $18544.0 in 2023, then increased by 20.9% to $22420.0 in 2024.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $22420.0 in Q4 2024, $7348.0 in Q3 2024, and $13470.0 in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.06 Bn | 626.30 Bn | 17.26 Bn |
| 2 | AbbVie | 440.06 Bn | 433.49 Bn | 12.70 Bn |
| 3 | Merck | 364.19 Bn | 357.05 Bn | 12.21 Bn |
| 4 | Novartis Ag | 268.45 Bn | 260.76 Bn | 11.24 Bn |
| 5 | Pfizer | 158.40 Bn | 146.70 Bn | 10.94 Bn |
| 6 | Sanofi | 52.57 Bn | 45.19 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.32 Bn | 44.32 Bn | - |
| 8 | Incyte | 24.98 Bn | 20.44 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.15 Bn | 18.49 Bn | 683.80 Mn |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 22,420.00 |
| Sep 30, 2024 | 7,348.00 |
| Jun 30, 2024 | 13,470.00 |
| Mar 31, 2024 | 19,324.00 |
| Dec 31, 2023 | 18,544.00 |
| Sep 30, 2023 | 19,048.00 |
| Jun 30, 2023 | 12,397.00 |
| Mar 31, 2023 | 16,667.00 |
| Dec 31, 2022 | 13,629.00 |
| Sep 30, 2022 | 21,945.00 |
| Jun 30, 2022 | 22,222.00 |
| Mar 31, 2022 | 26,936.00 |
| Dec 31, 2021 | 45,664.00 |
| Sep 30, 2021 | 111,224.00 |
| Jun 30, 2021 | 190,669.00 |
| Mar 31, 2021 | 40,471.00 |